While an extreme situation – such as the current COVID-19 pandemic – can uncover weaknesses we weren’t aware of in some companies, it also serves to further highlight problems that existed before.
Welcome to your daily cannabis investing resource
Detailed analysis and meaningful insight from industry experts.
Average trading multiples for U.S.-focused operators were up slightly versus last week, while the average stock price remained flattish. Canada-focused operators still trade at a premium on sales compared to U.S. operators.
The latest round of cannabis earnings highlight the potential long-term impacts of current conditions, driven by back-to-back crises and other events.
Executive conversations with industry pioneers and cannabis investing thought leaders.
The nascent marijuana industry has its share of cheerleaders and naysayers. This session examines both angles with two seasoned investors discussing the future of the cannabis market. This session provides insight on: • What to look for when assessing cannabis investing opportunities. • What the market’s enthusiasm gets right and wrong. • What could change […]
Cannabis stocks have been crushed with the market correction, but the long-term investment case is intact. Investor Intelligence equity research analysts Craig Benhke and Mike Regan provide a framework on how to invest now for the long term, exploring: Who does (and doesn’t) have the balance sheet and business plan to survive Where do valuations bottom […]
This Investor Intelligence exclusive webcast provides analysis of the outlook for cannabis portfolios in the coming months, with special guest Scott Greiper, president of Viridian Capital Partners.